mtf
-
Biologics
MTF Wound Care’s AmnioBand® and AlloPatch® Pliable Receive the American Podiatric Medical Association Seal of Approval
EDISON, N.J., Dec. 14, 2016 /PRNewswire/ – After evaluating each MTF Wound Care allograft in several areas – including safety, quality and…
Read More » -
Financial
MTF’s AmnioBand™ Receives High-Tier Reimbursement from Medicare to Treat Chronic Non-Healing Wounds in the Hospital Outpatient Setting
EDISON, N.J., Sept. 16, 2015 /PRNewswire/ — MTF, the Musculoskeletal Transplant Foundation (www.mtf.org) announced today that beginning October 1, AmnioBand™ Allograft Placental Matrix will…
Read More » -
Uncategorized
MiMedx Corrects A Second Inaccurate MTF Press Release
MARIETTA, Ga., Sept. 2, 2015 /PRNewswire/ — MiMedx Group, Inc. (NASDAQ: MDXG), the leading regenerative medicine company utilizing human amniotic tissue and patent-protected…
Read More » -
Hospitals
MTF Receives Favorable Ruling from the Patent Trial and Appeal Board in Patent Dispute with MiMedx
EDISON, N.J., Aug. 25, 2015 /PRNewswire/ — The Musculoskeletal Transplant Foundation (MTF) announced today the Patent Trial and Appeal Board (“PTAB”) has ruled…
Read More » -
Orthofix International Announces Preliminary Fourth Quarter Sales and New Development Agreement with MTF
LEWISVILLE, Texas–(BUSINESS WIRE)–Orthofix International N.V., (NASDAQ:OFIX) (the Company) announced today preliminary unaudited fourth quarter net sales are expected to be…
Read More »